href:http://www.thebell.co.kr/free/content/ArticleView.asp?key=202203041255495480102668&lcode=00&page=1&svccode=00

[Interview] “Dongtan RnD Center, iDear Center, will be an outpost of anti-cancer drugs”

The first interview article on Kilsoo Kang, CEO of Deargen, after he successfully secured the SeriesB funding round.

강길수 디어젠 대표이사, 시리즈B 완료 이후 첫 인터뷰 기사 공개